![Per Wold-Olsen](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Per Wold-Olsen
Chairman at
ONCOPEPTIDES AB
Net worth: 927 883 $ as of 30/05/2026
Profile
Per Wold-Olsen is a Norwegian businessperson who has been the head of 8 different companies. Currently, he is Chairman at GN Store Nord A, Chairman of GN Audio A, Chairman for GN Hearing An and Chairman for GN Netcom A (which are all subsidiaries of GN Store Nord A) and Chairman of Oncopeptides AB. He is also on the board of Gilead Sciences, Inc. and Bio Malter and Chairman of MMV Medicines for Malaria Venture. He previously occupied the position of President-Intercontinental Division at Merck & Co., Inc. and Chief Executive Officer for MSD (Norge) AS (a subsidiary of Merck & Co., Inc.), Regional Director & Vice President at MSD Scandinavia AS and Chairman-Supervisory Board for H. Lundbeck A. He received an MBA from the University of Wisconsin and an MBA from BI Norwegian Business School.
Known holdings in public companies
| Company | Date | Number of shares | Valuation | Valuation date |
|---|---|---|---|---|
SENZIME AB 0.72% | 22/09/2025 | 1,126,344 ( 0.72% ) | 605 061 $ | 30/05/2026 |
ONCOPEPTIDES AB 0.42% | 08/06/2026 | 1,646,802 ( 0.42% ) | 322 823 $ | 30/05/2026 |
Latest news about Per Wold-Olsen
Per Wold-Olsen active positions
| Companies | Position | Start |
|---|---|---|
| ONCOPEPTIDES AB | Chairman | 16/05/2018 |
| SENZIME AB | Chairman | 31/10/2023 |
Bio Malter | Director/Board Member | - |
Forepont Capital LLC
 Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Director/Board Member | - |
GN Hearing A/S
 GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Chairman | 15/06/2008 |
MMV Medicines for Malaria Venture
 MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Chairman | - |
Former positions of Per Wold-Olsen
| Companies | Position | End |
|---|---|---|
| GN STORE NORD A/S | Chairman | 14/03/2023 |
| AMARIN CORPORATION PLC | Chairman | 27/02/2023 |
| H. LUNDBECK A/S | Chairman | 29/03/2011 |
| ░░░░░░░░ ░░░░░░ ░░░░░░░░░ ░░░░ | ░░░░░░░░░░░░░░ ░░░░░░ | ░░░░░░░░░░ |
| ░░░░░ ░░░░░ ░░░░ ░░░░ | ░░░░░░░░░ ░░░░░░░░░░░░░░░░░ | ░░░░░░░░░░ |
Training of Per Wold-Olsen
Experiences
Positions held
Active
Inactive
Listed companies
Private companies
Connections
96
1st degree connections
23
1st degree companies
Male
Female
Members of the board
Executives
Linked companies
| Private companies | 23 |
|---|---|
Gilead Sciences, Inc.
 Gilead Sciences, Inc. BiotechnologyHealth Technology Discovers, develops and commercializes therapeutic products and treatments for life threatening diseases | Health Technology |
Merck & Co., Inc.
 Merck & Co., Inc. Pharmaceuticals: MajorHealth Technology Manufactures human and animal health pharmaceutical products & vaccines | Health Technology |
Amarin Corp. Plc
 Amarin Corp. Plc Pharmaceuticals: MajorHealth Technology Operates as biopharmaceutical company which develops and commercializes therapeutics to improve cardiovascular health | Health Technology |
Royal Numico NV
 Royal Numico NV Food: Specialty/CandyConsumer Non-Durables Manufactures baby food and clinical nutrition products | Consumer Non-Durables |
inVentiv Health Clinical, Inc.
 inVentiv Health Clinical, Inc. Miscellaneous Commercial ServicesCommercial Services Provides clinical research and drug development services | Commercial Services |
H. Lundbeck A/S
 H. Lundbeck A/S Pharmaceuticals: MajorHealth Technology Engages in the research, development, production and sale of pharmaceuticals for the treatment of brain diseases | Health Technology |
Glyconix Corp.
 Glyconix Corp. Pharmaceuticals: MajorHealth Technology Manufactures anti infective and oncology drugs | Health Technology |
Senzime AB
 Senzime AB Medical SpecialtiesHealth Technology Develops and markets an enzyme based biosensor technology | Health Technology |
GN Store Nord A/S
 GN Store Nord A/S Telecommunications EquipmentElectronic Technology Provides telecommunications and hearing instruments | Electronic Technology |
GN Audio A/S
 GN Audio A/S Electronic Production EquipmentElectronic Technology Develops, manufactures, and markets corded and wireless headsets, amplifiers for headsets, and headset telephones | Electronic Technology |
GN Hearing A/S
GN Hearing A/S Medical SpecialtiesHealth Technology Manufactures hearing-aid devices | Health Technology |
University of Wisconsin
 University of Wisconsin Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Oncopeptides AB
 Oncopeptides AB Pharmaceuticals: MajorHealth Technology Develops chemotherapeutic pharmaceuticals of compounds for cancer treatment | Health Technology |
Exiqon A/S
 Exiqon A/S Miscellaneous Commercial ServicesCommercial Services Engages in the pharmaceutical industry | Commercial Services |
BI Norwegian Business School
 BI Norwegian Business School Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
World Growth | |
MMV Medicines for Malaria Venture
MMV Medicines for Malaria Venture Miscellaneous Commercial ServicesCommercial Services Develops antimalarial drugs | Commercial Services |
PharmaSet SAS
 PharmaSet SAS Medical SpecialtiesHealth Technology Manufactures and distributes disposable healthcare kits for hospital use | Health Technology |
MSD (Norge) AS
 MSD (Norge) AS Pharmaceuticals: MajorHealth Technology Engages in researching, manufacturing and marketing of drugs | Health Technology |
Bio Malter | |
MSD Scandinavia AS | |
Novo Holdings A/S (Investment Company)
 Novo Holdings A/S (Investment Company) Financial ConglomeratesFinance Novo Holdings-IC aims to improve people’s health and the sustainability of society and the planet by generating attractive long-term returns on the assets of the Novo Nordisk Foundation. The firm invests in almost all life science segments including pharmaceuticals, biotechnology, medical technology, healthcare services and industrial BioSolutions. Outside of the life sciences they invest in a diversified portfolio of equities, fixed income, real assets and alternatives. | Finance |
Forepont Capital LLC
Forepont Capital LLC Investment ManagersFinance Forepont Capital Partners invests in companies located in United States, western Europe, Singapore, Australia, and Israel. The firm focuses on sectors such as biotech, medtech, and e-health. It participates in early-stage transactions. | Finance |
- Stock Market
- Insiders
- Per Wold-Olsen
